Breakthrough findings for the treatment of heart attack patients with cardiogenic shock

October 11, 2018, CORDIS
Breakthrough findings for the treatment of heart attack patients with cardiogenic shock
Credit: ARTTIC S.A.S.

Heart attacks with cardiogenic shock represent a major European healthcare concern with mortality rates between 40-70 percent. So how can it be treated best? The breakthrough findings of the five-year long CULPRIT-SHOCK multi-center study give a clear answer to this question and even lead to a change of the Guidelines of the European Society of Cardiology.

Cardiogenic shock complicating acute (AMI) represents a major European healthcare concern with between 40-70 percent. The clinician is faced with the decision to either intervene only on the culprit lesion acutely responsible for the initiation of cardiogenic shock, or treat additional lesions considered hemodynamically significant but not acutely triggering the shock cascade as well.

Credit: ARTTIC S.A.S.

Current guidelines recommend (PCI) of all critical lesions. However, due to a lack of randomized trials, these recommendations are solely based on registry data and pathophysiological considerations. The aim of the randomized CULPRIT-SHOCK trial has therefore been to compare immediate multivessel PCI versus culprit-lesion-only PCI in patients with AMI complicated by cardiogenic shock.

Credit: ARTTIC S.A.S.

For the study, a total of 706 cardiogenic shock patients have been randomized in 11 European countries. CULPRIT-SHOCK clarified the role of different percutaneous revascularization strategies in patients with cardiogenic shock secondary to myocardial infarction and multivessel disease. CULPRIT-SHOCK is now the largest randomized controlled clinical trial in patients with cardiogenic shock ever conducted and will inform patients, healthcare providers, and decision-makers about which percutaneous revascularization strategy is most effective.

Credit: ARTTIC S.A.S.

Explore further: Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

Related Stories

Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

October 31, 2017
Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found that an initial strategy of culprit lesion only percutaneous coronary intervention (PCI) reduces the composite of 30-day mortality and/or severe ...

Six variables can predict mortality risk in cardiogenic shock

April 14, 2017
(HealthDay)—Six variables can be combined to predict short-term mortality risk in patients with cardiogenic shock (CS), according to a study published in the April 18 issue of the Journal of the American College of Cardiology.

Successful cardiogenic shock treatment using a percutaneous left ventricular assist device

October 31, 2017
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous ...

Intraaortic balloon pump fails to improve mortality rate in cardiogenic shock patients: The IABP-SHOCK II study

August 27, 2012
A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people. However, there is still ...

Heart attack patients with cardiogenic shock fair well 60 days post-discharge

February 15, 2016
Heart attack patients who experience cardiogenic shock have a higher risk of death or rehospitalization than non-shock patients in the first 60 days post-discharge, but by the end of the first year, the gap between the two ...

Patient-level model predicts in-hospital mortality in acute MI

August 4, 2016
(HealthDay)—A parsimonious patient-level clinical risk model can predict in-hospital mortality for patients with acute myocardial infarction, according to a study published in the Aug. 9 issue of the Journal of the American ...

Recommended for you

Can stem cells help a diseased heart heal itself? Researchers achieve important milestone

December 14, 2018
A team of Rutgers scientists, including Leonard Lee and Shaohua Li, have taken an important step toward the goal of making diseased hearts heal themselves—a new model that would reduce the need for bypass surgery, heart ...

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

Your weight history may predict your heart failure risk

December 12, 2018
In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide ...

Age is the biggest risk for heart disease, but lifestyle and meds have impact

December 12, 2018
Of all the risk factors for heart disease, age is the strongest predictor of potential trouble.

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

aaronpaul456
not rated yet Oct 12, 2018
Heart Valve Therapy is a dedicated interventional cardiologist with experience in both adult, pediatric and peripheral interventions. He is capable of performing TAVI, left atrial appendage closures, renal artery denervation apart from complex coronary and pediatric structural heart disease interventions. He also performs carotid and aorto-iliac interventions including intervention for aortic aneurysm and dissections.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.